Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Revvity Omics, |
RCV003145864 | SCV003829924 | uncertain significance | Deficiency of ferroxidase | 2019-07-31 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004614410 | SCV005111599 | uncertain significance | Inborn genetic diseases | 2024-04-12 | criteria provided, single submitter | clinical testing | The c.1169T>C (p.I390T) alteration is located in exon 6 (coding exon 6) of the CP gene. This alteration results from a T to C substitution at nucleotide position 1169, causing the isoleucine (I) at amino acid position 390 to be replaced by a threonine (T). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |